Study of Combined Oral Contraceptive Effects in Female Subjects

NCT02157467 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2018-04-17

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of BMS-955176 on the pharmacokinetics of coadministered oral contraceptives.

Conditions

  • Infection, Human Immunodeficiency Virus

Interventions

DRUG

BMS-955176

DRUG

Ortho Cyclen

Sponsors & Collaborators

Principal Investigators

  • Viiv Clinical Trials · ViiV Healthcare

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-02
Primary Completion
2014-08-25
Completion
2014-08-25

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02157467 on ClinicalTrials.gov